EUVIMEDSkopri EUVIMED
Open access · CC BY-NC 4.0

The REV‐ERB antagonist SR8278 modulates keratinocyte viability in response to UVA and UVB radiation

William Cvammen, Michael G Kemp iD

Photochemistry and Photobiology · 2024

DOI: 10.1111/php.13930 ↗

At a glance

Journal article in Photochemistry and Photobiology, 2024. Written by William Cvammen and 1 co-authors. Institution: Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA. Major MEDLINE topics: Ultraviolet Rays, Keratinocytes, Cell Survival, Nuclear Receptor Subfamily 1, Group D, Member 1. Cited 5 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Veterans Administration, CSRD VA, Ohio Cancer Research Associates.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The nucleotide excision repair (NER) system removes UV photoproducts from genomic DNA and is controlled by the circadian clock. Given that small‐molecule compounds have been developed to target various clock proteins, we examined whether the cryptochrome inhibitor KS15 and REV‐ERB antagonist SR8278 could modulate keratinocyte responses to UV radiation in vitro. We observed that though SR8278 promoted cell viability in UVB‐irradiated cells, it had little effect on NER or on the expression of the clock‐regulated NER factor XPA. Rather, we found that both KS15 and SR8278 absorb light within the UV spectrum to limit initial UV photoproduct formation in DNA. Moreover, SR8278 promoted UVB viability even in cells in which the core circadian clock protein BMAL1 was disrupted, which indicates that SR8278 is likely acting via other REV‐ERB transcriptional targets. We further observed that SR8278 sensitized keratinocytes to light sources containing primarily UVA wavelengths of light likely due to the generation of toxic reactive oxygen species. Though other studies have demonstrated beneficial effects of SR8278 in other model systems, our results here suggest that SR8278 has limited utility for UV photoprotection in the skin and will likely cause phototoxicity in humans or mammals exposed to solar radiation.

Subjects

MeSH terms (MEDLINE)

Ultraviolet RaysKeratinocytesCell SurvivalNuclear Receptor Subfamily 1, Group D, Member 1HumansDNA RepairThiophenesIsoquinolines

Author keywords

DNA damageDNA damage response signalingDNA repairUV radiationcircadian clockphotoprotectionphototoxicityreactive oxygen speciessmall molecules

Substances

Nuclear Receptor Subfamily 1, Group D, Member 1SR 8278ThiophenesIsoquinolines

Authors and institutions

  • Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA.
  • Dayton Veterans Administration Medical Center, Dayton, Ohio, USA.

ORCID profiles: Michael G Kemp

Funding

  • Veterans Administration
  • CSRD VA
  • Ohio Cancer Research Associates
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Cite

APA

Cvammen, W., & Kemp, M. G. (2024). The REV‐ERB antagonist SR8278 modulates keratinocyte viability in response to UVA and UVB radiation. Photochemistry and Photobiology. https://doi.org/10.1111/php.13930

Vancouver

Cvammen W, Kemp MG. The REV‐ERB antagonist SR8278 modulates keratinocyte viability in response to UVA and UVB radiation. Photochemistry and Photobiology. 2024. doi:10.1111/php.13930

BibTeX
@article{Cvammen2024,
  author = {Cvammen, William and Kemp, Michael G},
  title = {The REV‐ERB antagonist SR8278 modulates keratinocyte viability in response to UVA and UVB radiation},
  journal = {Photochemistry and Photobiology},
  year = {2024},
  doi = {10.1111/php.13930}
}
Start for free →